Patents Assigned to EXCELIMMUNE, INC.
  • METHODS FOR PRODUCING RECOMBINANT PROTEINS
    Publication number: 20140127743
    Abstract: Methods for producing recombinant cell populations are disclosed. The disclosed methods may be used to produce therapeutic polyclonal proteins.
    Type: Application
    Filed: September 26, 2013
    Publication date: May 8, 2014
    Applicant: Excelimmune, Inc.
    Inventors: Vincent W. Coljee, Gwendolyn M. Wilmes, Stuart Hicks, Kimberly L. Carey, Elizabeth R. Reczek
  • Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof
    Publication number: 20140030269
    Abstract: Human antibodies that bind to one or more strains Staphylococcus aureus strains, including methicillin resistant strains, are disclosed. Also disclosed are human recombinant polyclonal antibody compositions, and therapeutic methods for using the antibodies.
    Type: Application
    Filed: July 26, 2013
    Publication date: January 30, 2014
    Applicant: Excelimmune, Inc.
    Inventor: Vincent W. Coljee
  • Methods for producing recombinant proteins
    Patent number: 8617881
    Abstract: Methods for producing recombinant cell populations are disclosed. The disclosed methods may be used to produce therapeutic polyclonal proteins.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: December 31, 2013
    Assignee: Excelimmune, Inc.
    Inventors: Vincent W. Coljee, Gwendolyn M. Wilmes, Stuart Hicks, Kimberly L. Carey, Elizabeth R. Reczek
  • METHODS FOR PRODUCING RECOMBINANT PROTEINS
    Publication number: 20120302464
    Abstract: Methods for producing recombinant cell populations are disclosed. The disclosed methods may be used to produce therapeutic polyclonal proteins.
    Type: Application
    Filed: June 13, 2012
    Publication date: November 29, 2012
    Applicant: EXCELIMMUNE, INC.
    Inventor: Vincent W. Coljee